Back
Olema Pharmaceuticals, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
63
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$27.66
Seasonality Move:
-18.94%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiOlema Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Olema Pharmaceuticals, Inc. has on average historically risen by 83.3% based on the past 5 years of stock performance.
-
Olema Pharmaceuticals, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Olema Pharmaceuticals, Inc. Stock Undervalued?The current Olema Pharmaceuticals, Inc. [OLMA] share price is $27.64. The Score for OLMA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Olema Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Olema Pharmaceuticals, Inc. has on average historically risen by 83.3% based on the past 5 years of stock performance.
Olema Pharmaceuticals, Inc. Stock Rating
Buy
63
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. overpriced?
-
Olema Pharmaceuticals, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Olema Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
olema.com
52-Week Data
52-Week High:
29.51
52-Week Low:
2.86
Prediction Charts
Market Cap:
1.9B
Price in USD:
27.64
Volume:
2.9M
Beta:
1.76
Technical Analysis
SMA50:
13.04
SMA100:
9.53
SMA200:
6.99
52-Wk Change:
173.93%
Stock Predictions
-
Is Olema Pharmaceuticals, Inc. stock public?Yes, Olema Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Olema Pharmaceuticals, Inc. stock quote today?The Olema Pharmaceuticals, Inc. stock price is 27.64 USD today.
-
How to buy Olema Pharmaceuticals, Inc. stock online?You can buy Olema Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 7.90 | 8.40 | 8.80 | 7.82 |
| Nov-17 | 8.39 | 8.52 | 8.76 | 8.19 |
| Nov-18 | 26.46 | 20.14 | 27.17 | 18.11 |
| Nov-19 | 19.81 | 19.43 | 23.84 | 19.17 |
| Nov-20 | 20.52 | 22.01 | 24.83 | 20.03 |
| Nov-21 | 21.49 | 23.17 | 23.30 | 20.03 |
| Nov-24 | 23.21 | 25.05 | 25.08 | 22.57 |
| Nov-25 | 25.05 | 26.07 | 26.57 | 24.76 |
| Nov-26 | 26.08 | 28.12 | 29.51 | 25.80 |
| Nov-28 | 28.12 | 28.32 | 28.80 | 27.44 |
| Dec-1 | 27.57 | 27.95 | 28.66 | 27.40 |
| Dec-2 | 27.94 | 27.15 | 28.29 | 26.20 |
| Dec-3 | 27.15 | 27.25 | 27.85 | 26.62 |
| Dec-4 | 27.26 | 27.64 | 28.45 | 26.93 |
Olema Pharmaceuticals, Inc. Earnings
Olema Pharmaceuticals, Inc. Earnings Report: Per Share Olema Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Olema Pharmaceuticals, Inc. Forecast Revenue Growth
Olema Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Olema Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and a decrease next year of $0.48 per share.
* Olema Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.